FDA-Cleared Liofilchem MTS™ (MIC Test Strip) Ceftazidime-avibactam (CZA)

MIC C. freundii ATCC 8090_CZA.jpg

Liofilchem has received clearance from the FDA to market in the United States the Ceftazidime-avibactam (CZA) MTS™ (MIC Test Strip), a quantitative assay for determining the Minimum Inhibitory Concentration (MIC) of ceftazidime-avibactam against C. freundii, E. cloacae, E. coli, K. oxytoca, K. pneumonia, P. mirabilis, P. aeruginosa.

More technical details on the Ceftazidime-avibactam MIC Test Strip IFU
MTS™ (MIC Test Strips) are porous strips with special features (International Patent) that are impregnated with a predefined concentration gradient of antibiotic, across 15 two-fold dilutions of a conventional MIC method. On one side of the strip there is a printed MIC scale in μg/mL and a code that identifies the antimicrobial agent.

MTS™ Ceftazidime-avibactam 0.016/4-256/4 μg/mL

  • 10 strip pack: ref. 921391
  • 30 strip pack: ref. 92139
  • 100 strip pack: ref. 921390

Ceftazidime-avibactam is the most recent FDA approved item in the MTS™ (MIC Test Strip) product range, following approvals of
VancomycinDalbavancinCeftolozane-tazobactamMeropenemCeftazidimeTelavancinTedizolidDelafloxacinClindamycin,  Erythromycin, Linezolid and Meropenem-vaborbactam strips.

In the meantime, the rest of the MTS™ range is available in the United States as research use only devices, while the entire MTS™ product catalog is CE marked and fully available as IVD for clinical diagnostics purposes in Europe and approved in Canada by Health Canada. MTS™ is also registered at the competent Authority in many countries outside Europe as a clinical diagnostic device.

The current MTS™ range comprises antibiotics, antifungals, antimycobacterials, and combined strips for detection of resistance mechanisms (ESBL, MBL, KPC, AmpC and GRD) for over 150 items, each available in three pack formats (10, 30 and 100), for the widest gradient strip range in the international market.

Tags: Antibiotic Sensitivity, MRSA, New Delhi Metallo-beta-lactamase NDM-1, Klebsiella pneumoniae carbapenemase (KPC), Minimum Inhibitory Concentration, Extended-Spectrum Beta-Lactamase ESBL, Antibiotic Resistance, ampC, Glycopeptide Resistance Detection (GRD)

Date Published: June 14, 2018

Source article link: Liofilchem s.r.l. » company contact details

Liofilchem s.r.l.

Roseto degli Abruzzi



Tel: +[39] 0858930745

Related news from
Liofilchem s.r.l.:

Similar subject:

Company general:

© 2001 - 2018 Rapid Test Methods Ltd • Please join us on Twitter, Facebook and LinkedIn • RSS Feed